Company Interviews

LIVETRADES interviews innovative, up and coming small cap companies

Financial Gravity $FGCO Offers Attractive Growth Opportunity in Tax Planning Services
20 Nov
2017
Written by Mike Elliott

Financial Gravity $FGCO Offers Attractive Growth Opportunity in Tax Planning Services »

Financial Gravity provides sophisticated tax planning for small to medium sized businesses helping them save thousands of dollars annually on their tax bill. Mr. Pollock discusses the size of the demand for tax planning services in this market and why has it been so neglected by the financial services industry with regards to better tax planning.

Read more...
Vuzix $VUZI Taking Augmented Reality By Storm with Award Winning Smart Glasses Technology
16 Nov
2017
Written by Mike Elliott

Vuzix $VUZI Taking Augmented Reality By Storm with Award Winning Smart Glasses Technology »

We are back again with Vuzix, a leading supplier of Smart Glasses, Augmented Reality technologies and products for the consumer and enterprise markets which trades under ticker VUZI.

Read more...
Newgioco Group $NWGI Pursues Multi-Billion Dollar Global Online Gambling Market
13 Nov
2017
Written by Mike Elliott

Newgioco Group $NWGI Pursues Multi-Billion Dollar Global Online Gambling Market »

Newgioco is a leisure betting technology company providing regulated lottery and gaming products and services throughout licensed subsidiaries in Europe. In this interview Mr. Ciavarella discusses the company's operations both here and in Europe as well as their cutting edge technology platform for online betting.

Read more...
Hemispherx $HEB Ramping Up Manufacturing to Pursue Multi-Billion Dollar Immuno-Oncology Market
13 Nov
2017
Written by Mike Elliott

Hemispherx $HEB Ramping Up Manufacturing to Pursue Multi-Billion Dollar Immuno-Oncology Market »

In this episode of CEOLIVE we’re joined by Mr. Thomas Equels, CEO of Hemispherx Biopharma, which trades on the NYSE under ticker HEB. Hemispherx is an advanced specialty pharmaceutical company engaged in the clinical development of new drug entities for treatment of seriously debilitating disorders.

Read more...
Citius Pharma $CTXR Receives “Fast Track” Designation By FDA For Potential $500M Product – Mino-Lok™
2 Nov
2017
Written by Mike Elliott

Citius Pharma $CTXR Receives “Fast Track” Designation By FDA For Potential $500M Product – Mino-Lok™ »

Citius is a specialty pharmaceutical company dedicated to the development and commercialization of unique therapeutic products in adjunctive cancer care with a focus on infectious diseases.

Read more...
BioSig’s $BSGM Disruptive Technology Nears Commercialization in $4B EP Market
26 Oct
2017
Written by Mike Elliott

BioSig’s $BSGM Disruptive Technology Nears Commercialization in $4B EP Market »

BioSig Technologies, Inc. is a Minnesota-based medical device company developing a proprietary technology platform designed to improve the rapidly growing multi-billion dollar electrophysiology (EP) marketplace.

Read more...

Login

Lost your password?